"10.1371_journal.pone.0030308","plos one","2012-02-10T00:00:00Z","Leanne M Johnson-Huang; Cara A Pensabene; Kejal R Shah; Katherine C Pierson; Toyoko Kikuchi; Tim Lentini; Patricia Gilleaudeau; Mary Sullivan-Whalen; Inna Cueto; Artemis Khatcherian; Luke A Hyder; Mayte Suárez-Fariñas; James G Krueger; Michelle A Lowes","Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, United States of America; Center for Clinical and Translational Science, The Rockefeller University, New York, New York, United States of America","Conceived and designed the experiments: JGK MAL. Performed the experiments: LJH CAP KCP TK TL IC AK. Analyzed the data: LJH CAP KRS KCP TK MSF MAL. Contributed reagents/materials/analysis tools: PG MSW JGK. Wrote the paper: LJH KRS MAL LAH.","The authors have read the journals policy and have the following conflicts: JGK has served as a consultant for Genentech, who provided efalizumab for the clinical trial. This does not alter the authorss adherence to all the PLoS ONE policies on sharing data and materials. Other authors declare that they have no competing interests related to this work.","2012","02","Leanne M Johnson-Huang","LMJH",14,FALSE,2,7,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
